DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

23.12.2019 / 22:16
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius Medical Care AG & Co. KGaA: Disclosure of a capital market information

- Share buy-back - 27th Interim Report

In the period from December 16, 2019 until and including December 20, 2019, a total of 188,844 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
16.12.2019 36,800 66.2337
17.12.2019 37,000 64.8663
18.12.2019 38,800 64.2261
19.12.2019 38,395 64.5977
20.12.2019 37,849 65.3689
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including December 20, 2019 therefore amounts to 5,107,678 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., December 23, 2019



23.12.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

942937  23.12.2019 

fncls.ssp?fn=show_t_gif&application_id=942937&application_name=news&site_id=zonebourse